Sirtuin 5 (SIRT5) is a NAD⁺-dependent mitochondrial deacylase belonging to the sirtuin family, class III histone deacetylases. It regulates diverse metabolic pathways, including glycolysis, fatty acid oxidation, and the tricarboxylic acid (TCA) cycle, through post-translational modifications such as desuccinylation, demalonylation, and deglutarylation . Emerging research highlights its dual roles in both physiological homeostasis and pathological conditions, including cancer, neurodegeneration, and cardiovascular diseases .
Recombinant human SIRT5 (32.5 kDa) is produced in E. coli with an N-terminal His-tag . Key applications include enzymatic assays and structural studies.
SIRT5 exhibits weak deacetylase activity but robust deacylase functions:
SIRT5’s deacetylase activity is uniquely resistant to nicotinamide inhibition (IC₅₀ = 1.6 mM vs. 43 µM for SIRT3) .
Its desuccinylase activity is highly sensitive to nicotinamide, mediated by Arg105 in the catalytic pocket .
GAPDH Demalonylation: Enhances glycolytic flux by activating glyceraldehyde-3-phosphate dehydrogenase .
PDH Regulation: Desuccinylates pyruvate dehydrogenase complex (PDC), suppressing pyruvate-to-acetyl-CoA conversion under stress .
VLCAD Desuccinylation: Stabilizes mitochondrial membrane localization of very-long-chain acyl-CoA dehydrogenase, boosting FAO .
ECHA Activation: Desuccinylates enoyl-CoA hydratase α-subunit, enhancing ATP production during fasting .
IDH2 Deglutarylation: Activates isocitrate dehydrogenase 2, supporting NADPH synthesis and antioxidant defense .
SIRT5 exhibits context-dependent roles in tumorigenesis:
High SIRT5 expression correlates with poor prognosis in breast cancer (HR = 1.67) .
SIRT5 copy-number gains occur in 25–60% of ovarian, melanoma, and breast tumors .
Myocardial Injury: SIRT5 deficiency reduces ATP synthesis and exacerbates oxidative stress during ischemia .
Cardiac Hypertrophy: Regulates succinate dehydrogenase (SDH-a) to mitigate ROS generation .
Compound | Target Activity | Effect |
---|---|---|
NRD-167 | SIRT5 inhibitor | Blocks desuccinylation, reduces tumor growth |
MC3138 | SIRT5 activator | Enhances G6PD activity, improves redox balance |
What is the biochemical function of human SIRT5?
Human SIRT5 functions primarily as a NAD+-dependent deacylase that removes succinyl, malonyl, and glutaryl groups from lysine residues on various proteins. Unlike other sirtuins that predominantly function as deacetylases, SIRT5 exhibits specialized activity toward these negatively charged acyl modifications .
Methodologically, SIRT5 activity can be assessed through:
Fluorescence-based deacylase activity assays
Mass spectrometry detection of substrate modifications
Targeted metabolic enzyme activity measurements
When studying SIRT5's enzymatic function, researchers should incorporate both in vitro biochemical assays and cellular systems to comprehensively characterize its activity profile.
How is SIRT5 distributed across human tissues and subcellular compartments?
Human SIRT5 exists in four isoforms with distinct subcellular localizations:
While cDNAs of all SIRT5 isoforms have been detected across multiple tissues, at the protein level, SIRT5 iso1 is most abundant, with iso2-4 rarely observed in human cell lines .
For accurate subcellular localization studies, researchers should employ:
Immunofluorescence microscopy with isoform-specific antibodies
Subcellular fractionation coupled with Western blotting
Expression of tagged isoforms with subsequent microscopy
What methodological approaches best assess SIRT5 enzymatic activity?
Quantifying SIRT5 activity requires careful consideration of assay conditions:
Method | Advantages | Limitations | Optimal Applications |
---|---|---|---|
Fluorescence-based assays | High throughput, sensitive | May not reflect physiological substrates | Initial screening, kinetic studies |
Mass spectrometry | Direct substrate modification detection | Requires specialized equipment | Comprehensive substrate identification |
Western blotting with modification-specific antibodies | Accessible, target-specific | Limited quantification | Validation of specific substrates |
Targeted metabolic enzyme assays | Functional relevance | Indirect measurement | Physiological impact assessment |
For robust enzymatic characterization, researchers should optimize for:
NAD+ concentration (typically 1-5 mM)
pH (optimal range 7.5-8.5)
Substrate specificity (preferably physiological targets)
Appropriate controls (inactive mutants, competitive inhibitors)
How do human SIRT5 variants affect enzyme structure and function?
Several clinically relevant SIRT5 variants have been identified with altered functional properties:
The crystal structure of the P114T enzyme shows only subtle deviations from wild-type, yet results in significant functional impairment . When investigating novel variants, researchers should employ:
Protein crystallography to determine structural alterations
Thermal stability assays to assess protein stability
Enzymatic activity measurements comparing wild-type and variant proteins
Cellular studies examining protein half-life and expression levels
Metabolic profiling to identify downstream consequences
What is the relationship between SIRT5 and metabolic dysregulation in disease models?
SIRT5 deficiency manifests differently depending on genetic background, sex, and environmental factors:
In animal models, SIRT5 knockout mice exhibit:
Greater glucose intolerance than wild-type counterparts regardless of sex
Sex-specific differences in body composition responses to high-fat diet
Enhanced cartilage degradation, particularly exacerbated by high-fat diet in males
To investigate SIRT5's metabolic functions, researchers should consider:
Sex-stratified analyses due to observed sexual dimorphism
Dietary interventions (particularly high-fat diet) to reveal phenotypes
Combined measurement of systemic metabolism and tissue-specific effects
Longitudinal studies to capture age-dependent phenotypes
How does SIRT5 regulate the mitochondrial proteome?
SIRT5 significantly impacts the mitochondrial lysine succinylome, with quantitative proteomics revealing:
32% of succinylated lysine sites increase more than twofold in SIRT5 knockout models
SIRT5 targets exhibit specific sequence preferences, with enrichment of serine or threonine at multiple positions (-8, -6, -5, -4, -1, +1, +3)
Approximately 29% of SIRT5 target sites are 100% conserved across seven vertebrate species
For comprehensive mitochondrial proteome analysis, researchers should implement:
Label-free quantitative proteomics comparing wild-type and SIRT5-deficient samples
Enrichment strategies for specific acyl modifications
Bioinformatic analyses to identify sequence motifs and pathway enrichment
Functional validation of key targets through directed enzymatic assays
What experimental approaches best capture SIRT5's role in cartilage metabolism and osteoarthritis?
Recent findings link SIRT5 to osteoarthritis development through regulation of chondrocyte metabolism:
Human OA-associated SIRT5^F101L mutation affects the catalytic domain and alters MaK levels
SIRT5-deficient mice exhibit early signs of proteoglycan loss and enhanced cartilage damage
High-fat diet exacerbates cartilage degeneration in SIRT5-deficient mice, particularly in males
Effective experimental approaches include:
Human genetic studies to identify disease-associated variants
Primary chondrocyte cultures from normal and osteoarthritic tissues
Tissue-specific conditional knockout models to distinguish local versus systemic effects
Proteomics to identify chondrocyte-specific SIRT5 substrates
Histological assessment with validated scoring systems (OARSI, Mankin scores)
How do genetic and environmental factors interact with SIRT5 function?
SIRT5 function is influenced by both genetic and environmental variables:
Tissue-specific conditional knockout models show different phenotypes than systemic knockouts
High-fat diet reveals metabolic phenotypes not apparent under standard conditions
Sex-specific differences in SIRT5-related phenotypes suggest hormonal influences
To investigate these interactions, researchers should design studies with:
Multiple genetic models (global vs. tissue-specific knockouts)
Environmental interventions (dietary modifications, stress conditions)
Sex-stratified analyses to capture hormonal influences
Age-dependent phenotyping to identify temporal effects
Multi-omics approaches to capture system-wide responses
What are the distinguishing characteristics of SIRT5 compared to other sirtuins?
SIRT5's unique properties among the sirtuin family include:
Feature | SIRT5 | Other Sirtuins |
---|---|---|
Primary enzymatic activity | Desuccinylase, demalonylase, deglutarylase | Primarily deacetylases (SIRT1,2,3) |
Subcellular localization | Mitochondrial and cytosolic isoforms | Various (nuclear, cytosolic, mitochondrial) |
Target sequence preference | Enrichment of serine/threonine at specific positions | Varies by sirtuin |
Metabolic pathway regulation | Carbon metabolism, glycolysis | Varies (e.g., SIRT3: fatty acid oxidation) |
Unlike SIRT3 deficiency, which causes severe consequences through protein hyperacetylation, SIRT5 deficiency produces more subtle phenotypes that may be revealed under stress conditions or with aging .
How conserved are SIRT5 targets across species?
Evolutionary analysis reveals high conservation of SIRT5 substrate sites:
72% of mouse SIRT5 target sites are conserved in humans
67% are conserved in zebrafish
About 29% of SIRT5 target sites are 100% conserved across seven vertebrate species
This remarkable conservation suggests fundamental metabolic functions under evolutionary pressure. Researchers investigating conserved targets should:
Perform comparative genomics across species
Validate conservation of both sequence and modification
Test cross-species activity with recombinant enzymes
Use conservation as a filter to prioritize functionally critical targets
What methodological considerations are important when developing mouse models of human SIRT5 variants?
When modeling human SIRT5 variants in mice, researchers should consider:
CRISPR-Cas9 gene editing to precisely recapitulate human mutations
Validation of protein expression, stability, and activity
Comprehensive phenotyping across multiple physiological systems
Exposing models to relevant environmental stressors
Comparing tissue-specific versus global expression of variants
The P114T mouse model recapitulates reduced SIRT5 levels and activity observed in humans but does not display overt metabolic abnormalities or neuropathology under standard conditions , highlighting the importance of appropriate stressors to reveal phenotypes.
How does SIRT5 contribute to redox homeostasis?
SIRT5 significantly impacts cellular redox balance through:
Regulation of enzymes involved in glutathione metabolism
Modification of proteins in the electron transport chain
Control of reactive oxygen species-detoxifying enzymes
Loss-of-function SIRT5 variants lead to significant disruption of redox homeostasis . For comprehensive assessment of SIRT5's role in redox regulation, researchers should measure:
Glutathione levels (reduced and oxidized)
Protein carbonylation as marker of oxidative damage
Mitochondrial ROS production
Activity of key antioxidant enzymes
NAD+/NADH ratios as indicators of redox state
What analytical challenges exist in studying the SIRT5 interactome?
Comprehensive analysis of SIRT5 interactions presents several technical challenges:
Challenge | Methodological Solution |
---|---|
Low abundance of some SIRT5 isoforms | Targeted enrichment strategies, overexpression systems |
Transient interactions | Crosslinking approaches, proximity labeling |
Multiple modification types | Pan-specific and modification-specific enrichment |
Compartment-specific interactions | Fractionation before analysis, in situ proximity labeling |
Distinguishing direct from indirect targets | In vitro validation with recombinant proteins |
Researchers should implement multiple complementary approaches and appropriate controls to comprehensively map the SIRT5 interactome across cellular compartments.
Sirtuin-5 (SIRT5) is a member of the sirtuin family of proteins, which are homologs to the yeast Sir2 protein. These proteins are characterized by a sirtuin core domain and belong to the class III histone deacetylases (HDACs), which are dependent on nicotinamide adenine dinucleotide (NAD+) as a co-factor for their enzymatic activities .
The SIRT5 gene is located on human chromosome 6p23 and consists of eight exons. The gene encodes two isoforms of the protein, one with 310 amino acids and another with 299 amino acids . The recombinant form of SIRT5 is typically expressed in Escherichia coli and has a molecular weight of approximately 59.8 kDa .
SIRT5 exhibits multiple enzymatic activities, including deacetylase, desuccinylase, demalonylase, and deglutarylase activities. These activities enable SIRT5 to remove acetyl, succinyl, malonyl, and glutaryl groups from lysine residues on proteins . This versatility in substrate specificity allows SIRT5 to play a crucial role in various cellular processes.
SIRT5 is primarily localized to the mitochondria, where it is involved in regulating several metabolic pathways. One of its key functions is the regulation of carbamoyl phosphate synthetase 1 (CPS1), an essential enzyme in the urea cycle. SIRT5 deacetylates CPS1, thereby stimulating its enzymatic activity and facilitating the detoxification of ammonia in the liver .
Additionally, SIRT5 has been shown to interact with and deacetylate cytochrome c, a component of the electron transport chain, suggesting a role in energy metabolism . Large-scale profiling studies have identified over 700 protein substrates for SIRT5, indicating its widespread influence on mitochondrial and cellular functions .